Human menopausal gonadotropins for anovulation and sterility. Results of 7 years of treatment

E. Rabau*, A. David, D. M. Serr, S. Mashiach, B. Lunenfeld

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

198 Scopus citations


Induction of ovulation with sequential application of human gonadotropins-follicle stimulating hormone (FSH) and luteinizing hormone (LH)-is today an established procedure. FSH, formerly obtained from animal sources and now extracted from urine of postmenopausal women (Pergonal), is available commercially and easy to administer. During the last 7 years, 110 patients suffering from various types of anovulation have been treated with 202 courses of Pergonal combined with human chorionic gonadotropins (HCG). The dosage of Pergonal was adjusted to the individual reaction of the patient, as evaluated by urinary estrogen excretion, the cervical mucus arborization test, and vaginal cytology. This treatment resulted in 61 pregnancies. There have been 34 deliveries, 11 patients are still pregnant, and there have been 16 abortions. Adverse reaction resulting from ovarian hyperstimulation were encountered. There is no relationship between the dosage of Pergonal administered and the severity or number of reactions. The combined administration of Pergonal with HCG can be regarded as a significant step forward in the treatment of anovulation.

Original languageEnglish
Pages (from-to)92-98
Number of pages7
JournalAmerican Journal of Obstetrics and Gynecology
Issue number1
StatePublished - 1 May 1967
Externally publishedYes


Dive into the research topics of 'Human menopausal gonadotropins for anovulation and sterility. Results of 7 years of treatment'. Together they form a unique fingerprint.

Cite this